Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2013

May 7, 2013

30291_dirs_2013-05-07_8b35ccb1-7529-4adb-b95c-58b1f02ea266.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-05-03

Reporting Person: Pawlicki Raymond (SVP, Chief Information Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-03 Common Stock F 866 $218.85 Disposed 8710.3777 Direct

Footnotes

F1: Includes 166.667 shares acquired under the Biogen Idec Inc. employee stock purchase plan on 3/28/2013.